Amgen Ltd invite you to this educational event to be held at The Royal Society, 6-9 Carlton House Terrace, London SW1Y 5AG, on Wednesday 23 September 2009 at 18.00. During this meeting, Dr David Hosking will introduce the current clinical perspectives on Primary Hyperparathyroidism (PHPT) and clinical indications for medical management of the condition. In addition Professor Claudio Marcocci will present pivotal trial data that ultimately led to the license for a new medical treatment option for non-surgical PHPT patients. Places at this meeting are limited. To register your attendance and for further information, please contact Kara Townsend at [email protected].